Meningitis Diagnosis and Treatment Market Research Report - Global Forecast till 2027

Meningitis Diagnosis and Treatment Market Research Report: by Type (Viral Meningitis, Bacterial Meningitis, and Others), by Treatment & Diagnosis (Treatment and Diagnosis), by End-user (Hospitals & Clinics, Others), and Region - Forecast till 2027

ID: MRFR/Pharma/4275-CR | April 2019 | Region: Global | 164 pages

Meningitis Diagnosis and Treatment Market Overview


The Meningitis Diagnosis and Treatment Market is expected to rise to a valuation of USD 430.2 million by 2023, rising at a solid 3.38% CAGR over the forecast period from 2018 to 2023. The meningitis diagnosis and treatment market is mainly driven by the growing prevalence of meningitis as well as the increasing efforts to combat the disease, including efforts to reduce the incidence of the disease as well as efforts to manage the disease better. The growing scope of the healthcare sector in emerging regions is likely to be a major driver for the meningitis diagnosis and treatment market over the forecast period.


Competitive Analysis


Leading players in the market include B. Braun Melsungen AG, Sanofi, Pfizer Inc., Siemens Healthcare Private Limited, GlaxoSmithKline plc, Merck KGaA, Baxter, Abbott, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Luminex Corporation, F. Hoffman-La Roche Ltd., Cepheid, and Pfizer Inc., hold dominant shares in the market.



  • A study conducted at the University of Liverpool found in June 2018 that viruses are the most common cause of meningitis in the UK. Such studies are likely to be important for the growth of the meningitis diagnosis and treatment industry over the forecast period.

  • In February 2019, researchers from the Pediatric Emergency Care Applied Research Network developed a new protocol that allows doctors to rule out the worst possibilities in patients below the age of 2 months, which eliminates the need for spinal tap procedures and antibiotics treatments, which can prove troublesome for the immune system of newborns.


Market Dynamics


The growing prevalence of viral and bacterial meningitis is likely to be a major driver for the meningitis diagnosis and treatment market over the forecast period. Meningitis is a pathogenic inflammation that affects the brain and spinal cord and can result in symptoms such as neck pain, fever, and headache. The disease can be fatal if allowed to develop and timely intervention is needed to keep the disease in check. The growing prevalence of pathogenic infections is likely to be a key driver for the meningitis diagnosis and treatment market over the forecast period.


The rising demand for point of care diagnostic services, especially for chronic diseases, is also likely to be a major driver for the growth of market over the forecast period.


On the other hand, the lack of awareness about meningitis in developing regions and the possibility of harmful side effects of antibiotics are likely to hold back the market growth over the forecast period.


Segmentation


The meningitis diagnosis and treatment market is segmented on the basis of disease type, service, end user, and region.


By disease type, the meningitis diagnosis and treatment market is segmented into bacterial meningitis, viral meningitis, fungal meningitis, and others. Both viral and bacterial meningitis segments accounted for more than 40% of the meningitis diagnosis and treatment market in 2017 and are likely to dominate the meningitis diagnosis and treatment industry over the forecast period. The viral meningitis segment accounted for the largest market share of the meningitis diagnosis and treatment market in 2017.


By service, the meningitis diagnosis and treatment market is segmented into treatment and diagnosis. The treatment segment is sub-segmented into antibiotics, steroids, antifungal drugs, and others, while the diagnosis segment is subdivided into blood tests, imaging, lumbar puncture, and others. Treatment accounted for a larger share in the of meningitis diagnosis and treatment, and is expected to grow at the highest CAGR over the forecast period.


By end user, the meningitis diagnosis and treatment market is segmented into hospitals & clinics, diagnostic centers, and others. The hospitals and clinics segment accounted for the largest market share of the meningitis diagnosis and treatment market in 2017 and was valued at USD 274.12 million. The segment is also expected to exhibit the fastest CAGR of 3.54% over the forecast period due to the growing demand for advanced meningitis diagnosis and treatment procedures in hospitals and clinics.


Regional Analysis


The Americas and Europe segments dominate the meningitis diagnosis and treatment market, holding first and second place in the global market, respectively. Moreover, Asia Pacific accounts for a significant market share in the meningitis diagnosis and treatment market. Also, the Asia Pacific market is expected to exhibit the highest CAGR of 4.07% over the forecast period due to the growing awareness about meningitis and the growing financial capacity of the healthcare sector in the region.


Market of Meningitis Diagnosis and Treatment, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa




Frequently Asked Questions (FAQ) :


Meningitis diagnosis and treatment market is projected to grow at a 3.38% CAGR between 2020-2027.

The Americas and Europe are expected to dominate the meningitis diagnosis and treatment market.

Meningitis diagnosis and treatment market is predicted to touch USD 430.2 million by 2023.

Rising prevalence of pathogenic infections and demand for point of care diagnostic services are the key factors driving the meningitis diagnosis and treatment market.

Harmful side effects and lack of awareness may limit the meningitis diagnosis and treatment market growth.

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 20

3.2 Scope of the Study 20

3.3 Assumptions & Limitations 20

3.3.1 Assumptions 20

3.3.2 Limitations 20

3.4 Market Structure 21

4 Research Methodology

4.1 Research Process 23

4.2 Primary Research 24

4.3 Secondary Research 25

4.4 Market Size Estimation 26

4.5 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 28

5.2.1 Large Patient Population 28

5.2.2 Increasing Prevalence of Bacterial, Viral, and Fungal Infections 29

5.2.3 Rising Demand for Point of Care Diagnostic Services for Chronic Diseases 29

5.3 Restraints 29

5.3.1 Side-Effects of Antibiotics and Steroids 29

5.3.2 Lack of Awareness About Meningitis 29

5.4 Opportunities 30

5.4.1 Research for the Development of Specific Drugs for the Treatment of Meningitis 30

5.5 Technology Trends and Assessment 30

5.5.1 Increasing Focus on Combination Therapies 30

6 Market Factor Analysis

6.1.1 R&D and Designing 32

6.1.2 Manufacturing 32

6.1.3 Distribution & Sales 32

6.1.4 Post-Sales Monitoring 32

6.2 Porter’s Five Forces Model 33

6.2.1 Bargaining Power of Suppliers 33

6.2.2 Bargaining Power of Buyers 33

6.2.3 Threat of New Entrants 34

6.2.4 Threat of Substitutes 34

6.2.5 Intense Rivalry 34

6.3 Investment Opportunity Analysis 35

6.3.1 Market size (current and future), growth rate, and profitability 35

6.3.2 Investment Risks 35

6.3.3 Market Outlook 35

6.3.4 Competitors 36

6.3.5 Projections 36

6.4 Meningitis Tests (Number of tests for the Europe region) 36

7 Global Meningitis Diagnosis and Treatment Market, by Type

7.1 Introduction 38

7.2 Viral Meningitis 40

7.3 Bacterial Meningitis 41

7.4 Fungal Meningitis 42

8 Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis

8.1 Introduction 44

8.2 Treatment 47

8.2.1 Antibiotics 48

8.2.2 Steroids 49

8.2.3 Antifungal Drugs 50

8.3 Diagnosis 51

8.3.1 Spinal Tap (Lumbar Puncture) 52

8.3.2 Imaging Techniques 53

8.3.3 Blood Tests 54

9 Global Meningitis Diagnosis and Treatment Market, by End User

9.1 Introduction 56

9.2 Hospitals & Clinics 58

9.3 Diagnostic Centers 59

10 Global Meningitis Diagnosis and Treatment Market, by Region

10.1 Introduction 61

10.2 Americas 63

10.2.1 North America 66

10.2.1.1 US 69

10.2.1.2 Canada 72

10.2.2 Latin America 74

10.3 Europe 77

10.3.1 Western Europe 80

10.3.1.1 UK 83

10.3.1.2 France 86

10.3.1.3 Germany 88

10.3.1.4 Spain 91

10.3.1.5 Italy 93

10.3.1.6 Rest of Western Europe 96

10.3.2 Eastern Europe 98

10.4 Asia-Pacific 101

10.4.1 China 104

10.4.2 Japan 107

10.4.3 India 109

10.4.4 Australia 112

10.4.5 South Korea 114

10.4.6 Rest of Asia-Pacific 117

10.5 Middle East & Africa 120

10.5.1 Middle East 123

10.5.2 Africa 126

11 Competitive Landscape

11.1 Introduction 130

11.2 Company Market Share Analysis 130

12 Company Profiles

12.1 B. Braun Melsungen AG 133

12.1.1 Company Overview 133

12.1.2 Financial Overview 133

12.1.3 Products/Services Offered 134

12.1.4 Key Developments 134

12.1.5 SWOT Analysis 134

12.1.6 Key Strategy 134

12.2 Sanofi 135

12.2.1 Company Overview 135

12.2.2 Financial Overview 135

12.2.3 Products/Services Offered 136

12.2.4 Key Developments 136

12.2.5 SWOT Analysis 136

12.2.6 Key Strategy 136

12.3 Pfizer Inc. 137

12.3.1 Company Overview 137

12.3.2 Financial Overview 137

12.3.3 Products/Services Offered 138

12.3.4 Key Developments 138

12.3.5 SWOT Analysis 138

12.3.6 Key Strategy 138

12.4 Siemens Healthcare Private Limited 139

12.4.1 Company Overview 139

12.4.2 Financial Overview 139

12.4.3 Products/Services Offered 140

12.4.4 Key Developments 140

12.4.5 SWOT Analysis 140

12.4.6 Key Strategy 140

12.5 GlaxoSmithKline Plc. 141

12.5.1 Company Overview 141

12.5.2 Financial Overview 141

12.5.3 Products/Services Offered 142

12.5.4 Key Developments 142

12.5.5 SWOT Analysis 142

12.5.6 Key Strategy 142

12.6 Merck KGaA 143

12.6.1 Company Overview 143

12.6.2 Financial Overview 143

12.6.3 Products/Services Offered 144

12.6.4 Key Developments 144

12.6.5 SWOT Analysis 144

12.6.6 Key Strategy 144

12.7 Baxter 145

12.7.1 Company Overview 145

12.7.2 Financial Overview 145

12.7.3 Products/Services Offered 146

12.7.4 Key Developments 146

12.7.5 SWOT Analysis 146

12.7.6 Key Strategy 146

12.8 Abbott 147

12.8.1 Company Overview 147

12.8.2 Financial Overview 147

12.8.3 Products/Services Offered 148

12.8.4 Key Developments 148

12.8.5 SWOT Analysis 148

12.8.6 Key Strategy 148

12.9 Bio-Rad Laboratories Inc. 149

12.9.1 Company Overview 149

12.9.2 Financial Overview 149

12.9.3 Products/Services Offered 150

12.9.4 Key Developments 150

12.9.5 SWOT Analysis 150

12.9.6 Key Strategy 150

12.10 Thermo Fisher Scientific Inc. 151

12.10.1 Company Overview 151

12.10.2 Financial Overview 151

12.10.3 Products/Services Offered 152

12.10.4 Key Developments 152

12.10.5 SWOT Analysis 152

12.10.6 Key Strategy 152

12.11 Quest Diagnostics Incorporated 153

12.11.1 Company Overview 153

12.11.2 Financial Overview 153

12.11.3 Products/Services Offered 154

12.11.4 Key Developments 154

12.11.5 SWOT Analysis 154

12.11.6 Key Strategy 154

12.12 Luminex Corporation 155

12.12.1 Company Overview 155

12.12.2 Financial Overview 155

12.12.3 Products/Services Offered 156

12.12.4 Key Developments 156

12.12.5 SWOT Analysis 156

12.12.6 Key Strategy 156

12.13 F. Hoffmann-La Roche Ltd 157

12.13.1 Company Overview 157

12.13.2 Financial Overview 157

12.13.3 Products/Services Offered 158

12.13.4 Key Developments 158

12.13.5 SWOT Analysis 158

12.13.6 Key Strategy 158

12.14 Cepheid 159

12.14.1 Company Overview 159

12.14.2 Financial Overview 159

12.14.3 Products/Services Offered 160

12.14.4 Key Developments 160

12.14.5 SWOT Analysis 160

12.14.6 Key Strategy 160

13 Appendix

13.1 Discussion Blue Print 162

14 List of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 PRIMARY INTERVIEWS 23

TABLE 3 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 39

TABLE 4 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR VIRAL MENINGITIS, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 5 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BACTERIAL MENINGITIS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR FUNGAL MENINGITIS, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 45

TABLE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR TREATMENT, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIBIOTICS, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR STEROIDS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR ANTIFUNGAL DRUGS, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 14 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 15 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR SPINAL TAP (LUMBAR PUNCTURE), BY REGION, 2020–2027 (USD MILLION) 52

TABLE 16 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR IMAGING TECHNIQUES, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 17 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR BLOOD TESTS, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 57

TABLE 19 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 58

TABLE 20 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION) 59

TABLE 21 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 62

TABLE 22 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 63

TABLE 23 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 24 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 64

TABLE 25 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 26 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 27 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 28 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66

TABLE 29 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 30 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 67

TABLE 31 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 32 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 33 NORTH AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 34 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 35 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 70

TABLE 36 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 37 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 38 US: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 39 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 40 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 72

TABLE 41 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 42 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 43 CANADA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 44 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 45 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 75

TABLE 46 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 47 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 48 LATIN AMERICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 76

TABLE 49 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 77

TABLE 50 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 51 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 78

TABLE 52 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 53 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 54 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 80

TABLE 55 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80

TABLE 56 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 57 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 81

TABLE 58 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 59 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 60 WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 83

TABLE 61 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 62 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 84

TABLE 63 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 64 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 65 UK: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 85

TABLE 66 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 67 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 86

TABLE 68 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 69 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 70 FRANCE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 88

TABLE 71 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 72 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 89

TABLE 73 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 74 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 75 GERMANY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 90

TABLE 76 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 77 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 91

TABLE 78 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 79 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 80 SPAIN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 93

TABLE 81 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 82 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 94

TABLE 83 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 84 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 85 ITALY: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 95

TABLE 86 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 87 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 96

TABLE 88 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 89 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 90 REST OF WESTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 91 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 92 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 99

TABLE 93 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 94 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 95 EASTERN EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 100

TABLE 96 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101

TABLE 97 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 98 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 102

TABLE 99 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 100 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 101 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 104

TABLE 102 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 103 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 105

TABLE 104 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 105 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 106 CHINA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 106

TABLE 107 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 108 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 107

TABLE 109 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 110 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 111 JAPAN: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 109

TABLE 112 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 113 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 110

TABLE 114 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 115 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 116 INDIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 111

TABLE 117 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 118 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 112

TABLE 119 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 120 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 121 AUSTRALIA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 114

TABLE 122 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 123 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 115

TABLE 124 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 125 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 126 SOUTH KOREA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 116

TABLE 127 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 128 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 117

TABLE 129 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 130 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 131 REST OF ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 119

TABLE 132 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 120

TABLE 133 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 134 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 121

TABLE 135 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 136 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 137 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 123

TABLE 138 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 139 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 124

TABLE 140 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 124

TABLE 141 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 142 MIDDLE EAST: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 125

TABLE 143 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 126

TABLE 144 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020–2027 (USD MILLION) 126

TABLE 145 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 146 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, FOR DIAGNOSIS, BY TYPE 2020–2027, (USD MILLION) 127

TABLE 147 AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 128


15 List of Figures

FIGURE 1 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET: MARKET STRUCTURE 21

FIGURE 2 RESEARCH PROCESS 23

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 4 SUPPLY CHAIN: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET 32

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET 33

FIGURE 6 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TYPE, 2020(%) 38

FIGURE 7 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 38

FIGURE 8 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY TREATMENT & DIAGNOSIS, 2020 (%) 44

FIGURE 9 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2027 (USD MILLION) 44

FIGURE 10 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY END USER, 2020(%) 56

FIGURE 11 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY END USER, 2020 & 2027 (USD MILLION) 56

FIGURE 12 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2020(%) 61

FIGURE 13 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, BY REGION, 2020 & 2027 (USD MILLION) 61

FIGURE 14 AMERICAS: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2020 (%) 63

FIGURE 15 EUROPE: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2020 (%) 77

FIGURE 16 ASIA-PACIFIC: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%) 101

FIGURE 17 MIDDLE EAST & AFRICA: MENINGITIS DIAGNOSIS AND TREATMENT MARKET SHARE, BY REGION, 2020 (%) 120

FIGURE 18 GLOBAL MENINGITIS DIAGNOSIS AND TREATMENT MARKET, COMPANY MARKET SHARE ANALYSIS, 2020 (%) 130